tiprankstipranks
Advertisement
Advertisement

JAZZ Stock Latest News

Jazz Pharmaceuticals reports Q2 adjusted EPS $5.71, consensus $6.18
The FlyJazz Pharmaceuticals reports Q2 adjusted EPS $5.71, consensus $6.18
6h ago
JAZZ
Jazz Pharmaceuticals raises 2026 revenue guidance view to $4.6B-$4.75
PremiumThe Fly
Jazz Pharmaceuticals raises 2026 revenue guidance view to $4.6B-$4.75
6h ago
JAZZ
JAZZ Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
JAZZ Upcoming Earnings Report: What to Expect?
3d ago
JAZZ
Jazz Pharmaceuticals Advances JZP3507 Trial in Aggressive Brain Tumors
PremiumCompany Announcements
Jazz Pharmaceuticals Advances JZP3507 Trial in Aggressive Brain Tumors
4d ago
JAZZ
Jazz Pharmaceuticals Targets Adult LGS Growth With New Cannabidiol Dosing Study
PremiumCompany Announcements
Jazz Pharmaceuticals Targets Adult LGS Growth With New Cannabidiol Dosing Study
7d ago
JAZZ
Jazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy
PremiumCompany AnnouncementsJazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy
10d ago
JAZZ
Jazz Targets Epilepsy Growth With New JZP926 Trial in Juvenile Myoclonic Epilepsy
Premium
Company Announcements
Jazz Targets Epilepsy Growth With New JZP926 Trial in Juvenile Myoclonic Epilepsy
10d ago
JAZZ
Jazz Pharmaceuticals Shareholders Reaffirm Board and Governance Plans
Premium
Company Announcements
Jazz Pharmaceuticals Shareholders Reaffirm Board and Governance Plans
11d ago
8K
JAZZ
Jazz Targets Lung Cancer Growth With New Lurbinectedin–Durvalumab Trial
PremiumCompany Announcements
Jazz Targets Lung Cancer Growth With New Lurbinectedin–Durvalumab Trial
14d ago
JAZZ
Apple, Jazz, Moody’s, AEP, 3M Trending With Analysts
PremiumWeekend Updates
Apple, Jazz, Moody’s, AEP, 3M Trending With Analysts
17d ago
AEP
MCO
Apple upgraded, Brinker initiated: Wall Street’s top analyst calls
PremiumThe Fly
Apple upgraded, Brinker initiated: Wall Street’s top analyst calls
18d ago
EAT
ECL
Jazz Pharmaceuticals initiated with a Buy at Canaccord
PremiumThe Fly
Jazz Pharmaceuticals initiated with a Buy at Canaccord
18d ago
JAZZ
Jazz Pharmaceuticals initiated with a Buy at Canaccord
PremiumThe FlyJazz Pharmaceuticals initiated with a Buy at Canaccord
18d ago
JAZZ
Jazz Pharmaceuticals price target raised to $285 from $265 at Wells Fargo
Premium
The Fly
Jazz Pharmaceuticals price target raised to $285 from $265 at Wells Fargo
21d ago
JAZZ
Jazz Pharmaceuticals price target raised to $260 from $253 at Barclays
Premium
The Fly
Jazz Pharmaceuticals price target raised to $260 from $253 at Barclays
21d ago
JAZZ
Jazz Pharmaceuticals price target raised to $270 from $250 at Deutsche Bank
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $270 from $250 at Deutsche Bank
26d ago
JAZZ
Jazz Pharmaceuticals price target lowered to $254 from $256 at Truist
PremiumThe Fly
Jazz Pharmaceuticals price target lowered to $254 from $256 at Truist
28d ago
JAZZ
AbCellera upgraded to Buy from Hold at Benchmark
PremiumThe Fly
AbCellera upgraded to Buy from Hold at Benchmark
28d ago
ABCL
JAZZ
Jazz Pharmaceuticals, AbCellera collaborate for TCE multispecific antibodies
PremiumThe Fly
Jazz Pharmaceuticals, AbCellera collaborate for TCE multispecific antibodies
2M ago
ABCL
JAZZ
Jazz and AbCellera announce research collaboration for TCE antibodies
PremiumThe FlyJazz and AbCellera announce research collaboration for TCE antibodies
2M ago
ABCL
JAZZ
Jazz announces eleven presentations at SLEEP 2026
Premium
The Fly
Jazz announces eleven presentations at SLEEP 2026
2M ago
JAZZ
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
Premium
Market NewsSponsored
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
2M ago
GILD
JAZZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >